Browsing: Clinical > Infection control
Researchers have analyzed the microbiomes of flies, suggesting that these insects could have more disease-carrying potential than previously thought.
The FDA has approved Juluca®, the first two-drug regimen for maintenance treatment of HIV infection in adults, with the hope of presenting additional treatment options and lessening the burden on HIV-infected adults.
Nontuberculous mycobacteria (NTM) are increasingly recognized as important opportunistic pathogens of humans, the authors dicuss the clinical managment and treatments for nontuberculous mycobacterial infections.
Continuing our focus on antimicrobial resistance, Editor, Martha Powell, takes a closer look at the steps that can be taken to prevent the spread of drug resistance.
As part of our focus around World Antibiotic Awareness Week (13–19 November) we spoke to Professor Jonathan Cooke, a pharmacologist and pharmacist based in the UK who holds a special interest in antimicrobial resistance. He shares his thoughts on this pressing issue below:
Using live predatory bacteria as an alternative to traditional antibiotics had been suggested and studied over the last several years. Here we discuss some aspects of predatory bacteria that highlight their potential to serve as a possible antibiotic in the future.